Best Practice Advocacy Centre New Zealand , Dunedin , New Zealand.
Department of General Practice and Rural Health, Dunedin School of Medicine, University of Otago , Dunedin , New Zealand.
Clin Toxicol (Phila). 2019 Nov;57(11):1087-1094. doi: 10.1080/15563650.2019.1582777. Epub 2019 Feb 26.
While a number of developed countries have witnessed a decline in carbon monoxide (CO) deaths and increasing numbers of opioid-related fatalities, it is not known whether these or other trends have occurred in New Zealand. The aim of this study was, therefore, to review deaths due to poisoning in New Zealand, describe the causative substances, and identify any trends. Retrospective study reviewing New Zealand's poison-related death findings recorded in the National Coronial Information System (NCIS) database over the 6-year period 2008-2013. We identified 1402 poisoning-related deaths recorded in the NCIS database representing a mortality rate of 5.4 deaths/100,000 population per year. The mortality rate due to poisoning was higher in males (6.96/100,000) than females (3.83/100,000). Fatalities peaked in the 40-50-year age group with the highest proportion of intentional deaths occurring in people aged 80-90 years. Pharmaceuticals accounted for 731 fatalities (52%) and chemicals 431 (31%), with multiple exposures occurring in 399 cases (28.5%). While CO was the leading cause of death throughout the period ( = 303, 21.6%), there was a significant reduction in the rate of CO fatalities from 1.69/100,000 population in 2008 to 0.94/100,000 in 2013 (IRR (95% CI) 2013/2008 0.56 (0.37-0.83)). There was, however, no statistically significant change in either the opioid-related death rate or the total number of deaths. Methadone was the leading pharmaceutical cause of fatality and the third most common cause overall, followed by morphine and codeine, with zopiclone and clozapine equally ranked as the sixth most common cause. While New Zealand has not suffered an "opioid epidemic" and has experienced a significant decline in CO deaths, the overall death rate due to poisoning has remained high. The development of accessible, timely, and relevant toxicovigilance systems would support the early implementation of interventions to reduce the leading causes of fatal poisoning.
虽然一些发达国家的一氧化碳(CO)死亡人数有所下降,阿片类药物相关死亡人数有所增加,但新西兰是否出现了这些或其他趋势尚不清楚。因此,本研究旨在审查新西兰中毒相关死亡情况,描述导致这些死亡的物质,并确定任何趋势。
这是一项回顾性研究,分析了新西兰国家尸检信息系统(NCIS)数据库中 2008 年至 2013 年期间记录的与中毒相关的死亡情况。我们在 NCIS 数据库中确定了 1402 例中毒相关死亡病例,每年每 10 万人中有 5.4 人死于中毒。男性(6.96/100,000)的中毒死亡率高于女性(3.83/100,000)。40-50 岁年龄段的死亡率最高,80-90 岁人群的自杀死亡比例最高。药物占 731 例(52%),化学物质占 431 例(31%),399 例(28.5%)存在多种物质暴露。尽管 CO 一直是主要的死因( = 303,21.6%),但 CO 死亡率从 2008 年的每 10 万人 1.69 人下降到 2013 年的每 10 万人 0.94 人(2013 年与 2008 年的发病率比(IRR(95%CI)2013/2008 0.56(0.37-0.83))。阿片类药物相关死亡率或总死亡人数均无统计学意义上的变化。美沙酮是药物导致死亡的主要原因,也是总体上的第三大死因,其次是吗啡和可待因,佐匹克隆和氯氮平的死因相同,并列第六位。尽管新西兰没有遭受“阿片类药物流行”,且 CO 死亡人数显著下降,但中毒总死亡率仍然很高。建立方便、及时和相关的毒理学监测系统将支持早期实施干预措施,以减少主要的致命中毒原因。